Imageguided radiotherapy for bladder cancer

doi:10.3760/cma.j.issn.1673-422X.2014.08.015

Abstract

Abstract: Bladder cancer is a common malignant tumor in urinary system. The life quality of patients reduces obviously after radical resection of bladder. Comprehensive treatment including radiotherapy and chemotherapy after bladder preservation surgery plays an important role for the prevention of postoperative recurrence, preservation the function of bladder, and improving the life quality of patients. Imageguided radiotherapy can reduce the setup error and inner boundary caused by the movement of organs, and can alleviate the side reaction of radiation, and it also can provide basis of expanding boundary of planning target volume for the bladder cancer patients.

Key words: Urinary bladder neoplasms, Radiotherapy, Image-guided

Yang Aijie, Liu Jie, Wang Mingchen, Ma Ruizhong, Hao Furong. Imageguided radiotherapy for bladder cancer[J]. Journal of International Oncology, 2014, 41(8): 605-608.

References

［1］毕丽华, 刘斌, 张洪珍. 图像引导放射治疗的临床应用［J］. 国际肿瘤学杂志, 2010, 37(1): 37-40. ［2］ Jensen JB, Hyer S, Jensen KM. Incidence of occult lymphnode metastasis missed by standard pathological examination in patients with bladder cancer undergoing radical cystectomy［J］. Scand J Urol Nephrol, 2011, 45(6): 419-424. ［3］ Smith AB, Deal AM, Woods ME, et al. Muscleinvasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base［J］. BJU Int, 2013, In Press. ［4］ Quek ML, Stein JP, Daneshmand S, et al. A critical analysis of perioperative mortality from radical cystectomy［J］. J Urol, 2006, 175(3 Pt 1): 886-889. ［5］ Azria D, Riou O, Rebillard X, et al. Combined chemoradiation therapy with twiceweekly gemcitabine and cisplatin for organ preservation in muscleinvasive bladder cancer: longterm results of a phase 1 trial［J］. Int J Radiat Oncol Biol Phys, 2014, 88(4): 853-859. ［6］ Smith AB, Deal AM, Woods ME, et al. Muscleinvasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base［J］. BJU Int, 2013, In press. ［7］ GoossensLaan CA, Visser O, Hulshof MC, et al. Survival after treatment for carcinoma invading bladder muscle: a Dutch populationbased study on the impact of hospital volume［J］. BJU Int, 2012, 110(2): 226-232. ［8］ Burkhard FC, Roth B, Zehnder P, et al. Lymphadenectomy for bladder cancer: indications and controversies［J］. Urol Clin North Am, 2011, 38(4): 397-405. ［9］ Régnier , Nguyen TD, Beckendorf V, et al. Bladder cancer radiotherapy margins［J］. Cancer Radiother, 2013, 17(56): 470-476. ［10］ Sathiyan S, Ravikumar M, Varatharaj C, et al. IMRT implementation and patient specific dose verification with film and ion chamber array detectors［J］. Gulf J Oncolog, 2010, 1(8): 20-27. ［11］谭炳煦, 程玉峰. 锥形束CT的特点及其在胸部肿瘤精确放疗中摆位误差的临床研究［J］. 国际肿瘤学杂志, 2010, 37(3): 213-216. ［12］ BodaHeggemann J, Lohr F, Wenz F, et al. kV conebeam CTbased IGRT: a clinical review［J］. Strahlenther Onkol, 2011, 187(5): 284-291. ［13］ Bloedorn FG, Wizenberg MJ, Seydel HG, et al. Radiotherapy in the treatment of cancer of the bladder［J］. South Med J, 1967, 60(5): 539-544. ［14］ Rudat V, Hammoud M, Pillay Y, et al. Impact of the frequency of online verifications on the patient setup accuracy and setup margins［J］. Radiat Oncol, 2011, 6: 101. ［15］ Redpath AT, Muren LP. CTguided intensitymodulated radiotherapy for bladder cancer: isocentre shifts, margins and their impact on target dose［J］. Radiother Oncol, 2006, 81(3): 276-283. ［16］ Foroudi F, Pham D, Bressel M, et al. Bladder cancer radiotherapy margins: a comparison of daily alignment using skin, bone or soft tissue［J］. Clin Oncol (R Coll Radiol), 2012, 24(10): 673681. ［17］ Foroudi F, Pham D, Bressel M, et al. Intrafraction bladder motion in radiation therapy estimated from pretreatment and posttreatment volumetric imaging［J］. Int J Radiat Oncol Biol Phys, 2013, 86(1): 77-82. ［18］ Foroudi F, Wong J, Kron T, et al. Online adaptive radiotherapy for muscleinvasive bladder cancer: results of a pilot study［J］. Int J Radiat Oncol Biol Phys, 2011, 81(3): 765-771. ［19］ Pham D, Roxby P, Kron T, et al. Introduction of online adaptive radiotherapy for bladder cancer through a multicentre clinical trial (TransTasman Radiation Oncology Group 10.01): iessons learned［J］. J Med Phys, 2013, 38(2): 59-66. ［20］ Vestergaard A, Sndergaard J, Petersen JB, et al. A comparison of three different adaptive strategies in imageguided radiotherapy of bladder cancer［J］. Acta Oncol, 2010, 49(7): 1069-1076.

[1]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei. Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study [J]. Journal of International Oncology, 2024, 51(6): 326-331.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[4]	Qian Xiaotao, Shi Ziyi, Hu Ge. A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2024, 51(3): 151-156.
[5]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing. Progress of radiotherapy in oligometastatic non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(3): 170-174.
[6]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei. Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients [J]. Journal of International Oncology, 2024, 51(1): 37-42.
[7]	Zhao Xin, Fan Xuewu, Tian Long, Hu Yimin. Application and evaluation study of 3D ultrasound in image guided radiotherapy for prostate cancer [J]. Journal of International Oncology, 2024, 51(1): 43-49.
[8]	Cui Tenglu, Lyu lu, Sun Pengfei. Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma [J]. Journal of International Oncology, 2023, 50(9): 548-552.
[9]	Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai. Research progress on the application of combining radiotherapy and systemic therapy in breast cancer [J]. Journal of International Oncology, 2023, 50(6): 362-367.
[10]	Lyu Lu, Sun Pengfei. Gut flora and cervical cancer [J]. Journal of International Oncology, 2023, 50(6): 373-376.
[11]	Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association. Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy （2023 version） [J]. Journal of International Oncology, 2023, 50(4): 193-201.
[12]	Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng. Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance [J]. Journal of International Oncology, 2023, 50(4): 227-230.
[13]	Shi Xaioqi, Wang Hongyan. Research progress on the interaction between gut microbiota and radiation enteritis [J]. Journal of International Oncology, 2023, 50(4): 244-247.
[14]	Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun. Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases [J]. Journal of International Oncology, 2023, 50(3): 138-143.
[15]	Huang Huayu, Gong Hongyun, Song Qibin. Influencing factors of pneumonitis in the period of thoracic radiotherapy combined with immunotherapy [J]. Journal of International Oncology, 2023, 50(2): 102-106.